检索结果 - Роберто Пили
- Showing 1 - 20 results of 79
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
Prolyl hydroxylase 2 dependent and Von-Hippel-Lindau independent degradation of Hypoxia-inducible factor 1 and 2 alpha by selenium in clear cell renal cell carcinoma leads to tumor... 由 Sreenivasulu Chintala, Tanbir Najrana, Károly Tóth, Shousong Cao, Farukh A. Durrani, Роберто Пили, Youcef M. Rustum
出版 2012Artigo -
7
-
8
-
9
The association of pre-treatment neutrophil to lymphocyte ratio with response rate, progression free survival and overall survival of patients treated with sunitinib for metastatic... 由 Daniel Keizman, Maya Ish‐Shalom, Peng Huang, Mario A. Eisenberger, Роберто Пили, Hans J. Hammers, Michael A. Carducci
出版 2011Artigo -
10
-
11
Angiotensin system inhibitors and outcome of sunitinib treatment in patients with metastatic renal cell carcinoma: A retrospective examination 由 Daniel Keizman, Peng Huang, Mario A. Eisenberger, Роберто Пили, Jenny J. Kim, Emmanuel S. Antonarakis, Hans J. Hammers, Michael A. Carducci
出版 2011Artigo -
12
-
13
-
14
-
15
Class I Histone Deacetylase Inhibitor Entinostat Suppresses Regulatory T Cells and Enhances Immunotherapies in Renal and Prostate Cancer Models 由 Li Shen, Michael J. Ciesielski, Swathi Ramakrishnan, Kiersten Marie Miles, Leigh Ellis, Paula Sotomayor, Protul Shrikant, Robert A. Fenstermaker, Роберто Пили
出版 2012Artigo -
16
-
17
Antitumor effect of the histone deacetylase inhibitor LAQ824 in combination with 13-<i>cis</i>-retinoic acid in human malignant melanoma 由 Yukihiko Kato, Brenda Salumbides, Xiao-Fei Wang, David Z. Qian, Simon A. Williams, Yongfeng Wei, Tolib B. Sanni, Peter Atadja, Роберто Пили
出版 2007Artigo -
18
Crosstalk between Nrf2 and YAP contributes to maintaining the antioxidant potential and chemoresistance in bladder cancer 由 Eric Ciamporcero, Martina Daga, Stefania Pizzimenti, Antonella Roetto, Chiara Dianzani, Alessandra Compagnone, A Palmieri, Chiara Ullio, Luigi Cangemi, Роберто Пили, Giuseppina Barrera
出版 2017Artigo -
19
-
20
相关主题
Medicine
Internal medicine
Cancer
Oncology
Cancer research
Biology
Biochemistry
Gene
Renal cell carcinoma
Prostate cancer
Sunitinib
Chemistry
Genetics
Pharmacology
Pathology
Histone
Histone deacetylase
Angiogenesis
Cell biology
Gastroenterology
Adverse effect
Chemotherapy
Urology
Apoptosis
Progression-free survival
Clinical endpoint
Clinical trial
Immunology
Immune system
In vitro